Private Advisor Group’s Inovio Pharmaceuticals INO Stock Holding History

Private Advisor Group’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-851	Closed	-$18K	–	2024
2022 Q2	$18K	Buy	+851	New	+$24K	﹤0.01%	2078
2021 Q2	–	Sell	-963	Closed	-$107K	–	2016
2021 Q1	$107K	Sell	963 -210	-18%	-$27.6K	﹤0.01%	1798
2020 Q4	$125K	Buy	1,173 +3	+0.3%	+$399	﹤0.01%	1679
2020 Q3	$163K	Buy	1,170 +75	+7%	+$15.6K	﹤0.01%	1438
2020 Q2	$354K	Buy	+1,095	New	+$176K	﹤0.01%	1148

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Private Advisor Group's INO Position: Q3 2022 in Review

Private Advisor Group sold out of Inovio Pharmaceuticals (INO) in Q3 2022, closing a stake of 851 shares — an estimated $18K sold.

Private Advisor Group first reported a position in INO in Q2 2020 and held it in 5 quarters. The position peaked at $354K in Q2 2020. 182 funds tracked by Wall St. Rank hold INO as of Q3 2022.

Private Advisor Group reported no remaining Inovio Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Private Advisor Group sold 851 Inovio Pharmaceuticals shares in Q3 2022, an estimated $18K.
Private Advisor Group first reported a position in Inovio Pharmaceuticals in Q2 2020 and held it in 5 quarters.
Private Advisor Group's Inovio Pharmaceuticals position peaked at $354K in Q2 2020.
182 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2022.

Based on Private Advisor Group's 13F filing for Q3 2022, filed 14 Oct 2022.